302440 logo

SK Bioscience Co Ltd (302440)

SK bioscience Co.,Ltd. engages in the research and development, production, and distribution of vaccines and biopharmaceuticals in Korea and internationally. Its product portfolio includes Skycellflu, a cell cultured influenza surface antigen vaccine; Skycellflu 4-ga pre-filled syringe; pneumococcal vaccine for adult and infant; Skyzoster, a shingles virus v...

KOHealthcareBiotechnologyKorea

公司简介

股票代码
302440
ISIN代码
KR7302440003
货币
Korean Won (KRW)

联系信息

公司地址
310, Pangyo-ro, Seongnam-si, South Korea, 13494
联系电话
82 2 2008 2200
公司网站
https://www.skbioscience.co.kr
财年结束
December

财务亮点

市值
$999,999.99
毛利润(TTM)
$999,999.99
资产回报率(TTM)
-3.24%
EBITDA
$-999,999.99
收入(TTM)
$999,999.99